← All trials
NCT06937203
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 7, 2025
- Primary completion
- Jul 31, 2026
- Completion date
- Jul 31, 2026
- First posted
- Apr 22, 2025
- Last posted
- Sep 17, 2025
- Enrollment
- 126
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Arrowhead PharmaceuticalsLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.